IL-6/STAT3 SIGNALLING BLOCKADE PROTECTS AGAINST EXPERIMENTAL OSTEOARTHRITIS IN MICE

被引：3
|
作者：
Latourte, A. [1 ]
Maillet, J. [1 ]
Cherifi, C. [1 ]
Ea, H. [1 ]
Bouaziz, W. [1 ]
Funck-Brentano, T. [1 ]
Cohen-Solal, M. [1 ]
Hay, E. [1 ]
Richette, P. [1 ]
机构：
[1] Hop Lariboisiere, F-75475 Paris, France
来源：
OSTEOARTHRITIS AND CARTILAGE | 2016年 / 24卷
关键词：
D O I：
10.1016/j.joca.2016.01.674
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
621
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [1] Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
    Latourte, Augustin
    Cherifi, Chahrazad
    Maillet, Jeremy
    Ea, Hang-Korng
    Bouaziz, Wafa
    Funck-Brentano, Thomas
    Cohen-Solal, Martine
    Hay, Eric
    Richette, Pascal
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (04) : 748 - 755
  • [2] Loss of IL-6/Stat3 signalling drives metastatic prostate cancer in mice and men
    Pencik, Jan
    Schlederer, Michaela
    Gruber, Wolfgang
    Unger, Christine
    Walker, Steven M.
    Chalaris, Athena
    Marie, Isabelle
    Hassler, Melanie R.
    Javaheri, Tahereh
    Aksoy, Osman
    Blayney, Jaine K.
    Mazal, Peter
    Grebien, Florian
    Egger, Gerda
    Poli, Valeria
    Eferl, Robert
    Kennedy, Richard
    Fend, Falko
    Scharpf, Marcus
    Braun, Martin
    Perner, Sven
    Levy, David E.
    Malcolm, Tim
    Turner, Suzanne D.
    Haitel, Andrea
    Susani, Martin
    Moazzami, Ali
    Rose-Johns, Stefan
    Aberger, Fritz
    Merkel, Olaf
    Moriggl, Richard
    Culig, Zoran
    Dolznig, Helmut
    Kenner, Lukas
    CYTOKINE, 2015, 76 (01) : 112 - 112
  • [3] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Johnson, Daniel E.
    O'Keefe, Rachel A.
    Grandis, Jennifer R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (04) : 234 - 248
  • [4] Deregulated Il-6/stat3 Signalling In Lung Cancer Development
    Jenkins, B. J.
    Brooks, G.
    Ruwanpura, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Daniel E. Johnson
    Rachel A. O'Keefe
    Jennifer R. Grandis
    Nature Reviews Clinical Oncology, 2018, 15 : 234 - 248
  • [6] IL-6/STAT3/miR-34a protects against neonatal lung injury patients
    Liu, Huajun
    Liu, Wenbin
    Tang, Xueqing
    Wang, Taisen
    Sun, Xianlin
    Lv, Jie
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 4355 - 4361
  • [7] CHONDROPROTECTIVE EFFECTS OF IL-6 INHIBITION THROUGH BLOCKADE OF THE STAT3 PATHWAY
    Latourte, A.
    Cherifi, C.
    Ea, H. -K.
    Bouaziz, W.
    Funck-Brentano, T.
    Solal, M. Cohen
    Hay, E.
    Richette, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 661 - 661
  • [8] TREATMENT WITH IL-6 BLOCKADE IN PATIENTS WITH GAIN OF FUNCTION STAT3 MUTATIONS
    Castro-Wagner, Johana B.
    Kumar, Ashish R.
    Jolley, Christopher
    Vogel, Tiphanie P.
    Cooper, Megan A.
    Leiding, Jennifer W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 314 - 314
  • [9] IL-6 INDUCED GP130 DEPENDENT STAT3 ACTIVATION IN HEPATOCYTES PROTECTS AGAINST INITIATION AND PROGRESSION OF STEATOHEPATITIS IN MICE
    Kroy, Daniela C.
    Beraza, Naiara
    Dierssen, Uta
    Sander, Leif E.
    Erschfeld, Stephanie
    Trautwein, Christian
    Streetz, Konrad L.
    HEPATOLOGY, 2008, 48 (04) : 368A - 368A
  • [10] Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE -/- mice
    Luo, Pengcheng
    Shi, Wei
    Wang, Yina
    Ma, Haiyan
    Liu, Tianshu
    Yan, Dan
    Huo, Shengqi
    Guo, Junyi
    Wang, Moran
    Li, Chenglong
    Lin, Jiayuh
    Zhang, Cuntai
    Li, Sheng
    Lv, Jiagao
    Lin, Li
    LIFE SCIENCES, 2020, 261
12345